Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02252796 · ClinicalTrials.gov registry record · Phase 1
Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by West Virginia University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT02252796: Clinical Trial Phase 1 study, sponsored by West Virginia University.
NCT02252796 is a Phase 1 study that was terminated before completion, run by West Virginia University. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02252796, a Phase 1 study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will help researchers test the safety of hypofractionated dose of radiotherapy (HySBst) at different dose levels before or after chemo-radiation for Non Small Cell Lung Cancer.
Interventions
- DRUG Carboplatin
- DRUG Paclitaxel
- RADIATION Hypofractionated Stereotactic Boost
- RADIATION Image-guided IMRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-09 |
| Phase | Phase 1 |
Why NCT02252796 stopped before completion
NCT02252796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Carboplatin is the first listed.
NCT02252796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02252796 about?
NCT02252796 is a clinical study titled "Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer". This study will help researchers test the safety of hypofractionated dose of radiotherapy (HySBst) at different dose levels before or after chemo-radiation for Non Small Cell Lung Cancer.
What is the current status of trial NCT02252796?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2014-07. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02252796?
The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), Hypofractionated Stereotactic Boost (RADIATION), Image-guided IMRT (RADIATION).
Who is sponsoring clinical trial NCT02252796?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02252796's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia